Spyglass Pharma, Inc. (NASDAQ:SGP) Stock Has Average Target Price of $44.00
MarketBeat
Spyglass Pharma, Inc. (NASDAQ:SGP) has an average 12-month price target of $44.00 from eight analysts, indicating a "Moderate Buy" consensus despite the company missing its last quarterly earnings estimate. The clinical-stage company, which focuses on long-acting ophthalmic drug-delivery treatments like its SGP-310 implant for glaucoma, reported a quarterly loss of $0.59 per share. Several institutional investors have recently established positions in the company, which has a market cap of $904.
Read the full story
This is a short summary. The complete article is published by MarketBeat.
Headline and summary aggregated from public news feeds. For information only — not financial advice.